Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Nosocomial Pneumonia
Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Nosocomial Pneumonia
Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Nosocomial Pneumonia
Submitted by
admin
on October 31, 2009 - 12:02pm
Source:
PR-USA.net
News Tags:
Astellas
Theravance
pneumonia
Headline:
Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Nosocomial Pneumonia
Do Not Allow Advertisers to Use My Personal information
